Understand And Update Your Covid 19 Knowledge

Information

Price

Language

English

Module 1: Clinical pearls for diagnosing COVID-19 – Identifying early is the Key

Lecture Date: 23 May 2021

Faculty

Dr. Amita Nene

MD, DETRD, FCCP(USA), FCPS

Consultant Chest Physician & Sleep Medicine Specialist - Bombay Hospital & Medical Research Centre,
Executive member of influenza foundation in India and south Asian academy of sleep medicine.

Dr. R. Vijai Kumar

MBBS, MD, DTCD

Pulmonologist: Hyderabad Chest center,
Recipient of the International Fellowship of American Association of Respiratory Care (FAARC) 1992,
Recipient Fellowship of American College of Chest Physicians 1998,
Recipient of International Chest Foundation award (for Asthma Education) from ACCP 2000.

Learning Objectives

Unending pandemic
Transmission dynamics of SARS CoV-2
Varied clinical manifestations
How to distinguish between Flu and COVID?
Precautions while examining suspected COVID-19 patient
Diagnostic tests

i. RT-PCR, Rapid Antigen, Antibody

ii. Radiological – HRCT

Recommendations by Indian bodies (ICMR/State)
Clinical pearls for diagnosing COVID-19

Module 2: Management of Home Quarantine COVID-19 Patients

Lecture Date: 30 May 2021

Faculty

Dr. Neeraj Gupta

MD, FIPS, FNCCP

Founder President - Ajmer Chest Society
Honourable Member - Governing Body : INDIAN CHEST SOCIETY
Fellow, International Agency for Standards and Ratngs Department of Respiratory Medicine - Jawaharlal Nehru Medical College, Ajmer
Senior Consultant Chest Physician and Interventional Pulmonologist Chairman - State Task Force, RNTCP, State of Rajasthan

Dr. Rajesh Swarnakar

MBBS, DNB(Chest), DTCD, MNAMS, FCCUSA

National Secretary: Indian Chest Society
Director & Chief Consultant Pulmonologist
Department of Respiratory, Critical Care, Sleep Medicine and Interventional Pulmonology - Getwell Hospital & Research Institute, Dhantoli, Nagpur.

Learning Objectives

Home quarantine patients

i. Symptomatics vs Asymptomatics

ii. Analyze the Risk

Why Antivirals are necessary

i. Herd immunity – Far-fetched in reality!

ii. Transient Antibody response

iii. Prolonged RNA shedding

Early antiviral benefit

i. To curtail clinical course & Transmission

ii. To avoid the progression

Therapeutic options - HCQ & Ivermectin
Role of favipiravir

i. Key profile & pharmacology

ii. Global evidence & Recommendations

iii. Indian Phase 3 results

Recommendations by Indian bodies (ICMR/State)

Module 3: Management of High Risk and Severe Patients

Lecture Date: 06 June 2021

Faculty

Dr. DJ Christopher

BSc DTCD DNB FICS FAPSR FRCP(Glasg) FCCP(USA)

Professor- Department of Pulmonary Medicine, Christian Medical College, Vellore - 632004.
Immediate Past President, Indian Chest Society.
Course Director, Diploma in Allergy & Asthma(DAA)Member.
COVID Clinical Characterization and Management Research Expert group, WHO.
Member, Respiratory Support Working Group, WHO.

Dr. Indranil Halder

MBBS, DCH, MD (Pulmonary Medicine)

FCCP, FICP, European Diploma in Adult Respiratory Medicine.
Associate Professor & HOD Department of Pulmonary Medicine, College of Medicine & JNM Hospital, Kalyani, West Bengal University of Health Science.
Jagdish Bose National Scholar.

Learning Objectives

Clinical spectrum of COVID-19

i. Mild, Moderate, Severe and Critical

High risk patients for disease progression

i. Advancing age

ii. Comorbidities

iii. Raised biomarkers

Triage as per the Risk score
Consequences of progression in High risk patients

i. Cytokine storm

ii. Multiorgan inflammatory damage

Early antiviral benefit

i. To curtail clinical course & Transmission

ii. To avoid the progression

Therapeutic options

i. Non-hospitalized

ii. Hospitalized

Role of monoclonal antibodies
Managing complications

i. Recommendations by Indian bodies(ICMR/State)

Module 4: Long Haulers of Covid

Lecture Date: 13 June 2021

Faculty

Dr. Raja Dhar

MBBS (Cal), MD (Respiratory Medicine), MRCP (UK), MSc (UK) CCT (Respiratory and General Medicine UK), FCCP (USA), Diploma in Palliative Care (Newcastle University), Certificate in Education (Deeside University)

Director & Head of Department - Department of Pulmonology, C K Birla Hospitals.
Chair- Training and Education Initiatives: Indian Chest Society.
Director- Research & Training, National Allergy Asthma Bronchitis Institute.

Dr. G.C.Khilnani

MBBS,MD (Medicine),FCCP(USA),FAMS,FICP,FNCCP,FISDA

Chairman- PSRI Institute of Pulmonary, Critical care & Sleep medicine,PSRI Hospital, New Delhi.
Formerly Professor & Head of Department- Pulmonary, Critical care & Sleep Medicine, AIIMS, New Delhi.

Learning Objectives

Chronic COVID Syndrome
Which lingering symptoms are common?

i. CCoughing, Chronic fatigue, Body aches, Joint pain, Shortness of breath,
Loss of taste and smell,Difficulty sleeping, Headaches, Brain fog

Who are at risk of becoming long haulers?
Long term sequel

i. Lung

ii. Heart

iii. Coagulation

iv. Brain

v. Kidney

Evolving role of Post COVID clinic

Live Lecture FAQs

Which browser should I use?

The DocMode platform runs on the following browsers: Firefox, Chrome, Safari and Internet Explorer We generally encourage the use of, and fully support only, the latest version.

What kind of equipment do I need?

You only require a working computer/laptop/mobile and a stable internet connection and good audio (internal or external speakers, earphones or headset).

Does it cost anything to participate?

No. It is absolutely free of cost.

I can't attend the live lecture. Will the lecture be repeated? Is there any way to watch it later?

Yes, you can access the live lecture at a later date from your dashboard itself if you are enrolled for the same. Even if you haven’t enrolled for it, all live lectures hosted on DocMode.org are available for viewing under the Lectures section of the DocMode homepage.